Novo Nordisk ® n the first nine months of 2021 M TRx in the US 38.0 Wegovy TM launch in the US 16.7 11.2 Jan July Oct 2021 2021 2021 anded AOM Market • ~17,000 weekly Rx 19 weeks after launch • Initial demand exceeded supply • Supply/demand situation expected to stabilise early 2022 • Commercial formulary access around 60% • More than 70% of Wegovy TM prescriptions are new to the AOM class • Wegovy TM submitted in Japan Prescriptions ve),
Download PDF file